PMID- 19852949 OWN - NLM STAT- MEDLINE DCOM- 20100308 LR - 20131121 IS - 1872-6240 (Electronic) IS - 0006-8993 (Linking) VI - 1307 DP - 2010 Jan 11 TI - Effects of a structural analogue of salsolinol, 1-MeDIQ, on pituitary prolactin release and dopaminergic activity in the mediobasal hypothalamus in nursing sheep. PG - 72-7 LID - 10.1016/j.brainres.2009.10.033 [doi] AB - The prolactin release caused by salsolinol (a derivative of dopamine, DA) in rats could be prevented by its structural analogue 1-methyl-3,4-dihydroisoqinoline (1-MeDIQ). To study the participation of salsolinol in the neural stimulatory mechanism of prolactin release in lactating sheep, we tested whether 1-MeDIQ, acting at the central nervous system (CNS) level, would diminish basal prolactin release and reduce prolactin surge induced by suckling. A series of intracerebroventricular (icv) infusions of 1-MeDIQ (5 x 60 microg/60 microl/30 min, at 30-min intervals) were performed in nursing ewes (n=8) during the fifth week of lactation. Additionally, by combining these infusions with push-pull perfusion, we studied the concentration of dopaminergic components, i.e., salsolinol, DA and 3,4-dihydroxyphenylacetic acid (DOPAC) within the infundibular nucleus/median eminence (IN/ME) in four of the ewes. Treatment with 1-MeDIQ significantly (P<0.001) reduced either the basal prolactin release during the non-suckling period or the suckling-induced prolactin surge. Specifically, the suppressive effect occurred gradually, affecting both the duration and amplitude of the prolactin surge. In the control ewes, the perfusate salsolinol concentration increased significantly (P<0.001) during suckling, while in the ewes treated with 1-MeDIQ only vestigial amounts of this compound were found during the non-suckling period. No DA was detected in the perfusates collected from the IN/ME of control and 1-MeDIQ-treated groups and no significant differences were found in the DOPAC concentrations between these groups. In conclusion, 1-MeDIQ is able to inhibit prolactin secretion in lactating sheep, acting at the CNS level. In addition, one of the way of 1-MeDIQ action may be directed to the local salsolinol release within the mediobasal hypothalamus. FAU - Misztal, Tomasz AU - Misztal T AD - Department of Endocrinology, The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences, 05-110 Jablonna n/Warsaw, Poland. t.misztal@ifzz.pan.pl FAU - Gorski, Konrad AU - Gorski K FAU - Tomaszewska-Zaremba, Dorota AU - Tomaszewska-Zaremba D FAU - Fulop, Ferenc AU - Fulop F FAU - Romanowicz, Katarzyna AU - Romanowicz K LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20091021 PL - Netherlands TA - Brain Res JT - Brain research JID - 0045503 RN - 0 (1-methyl-3,4-dihydroisoquinoline) RN - 0 (Isoquinolines) RN - 102-32-9 (3,4-Dihydroxyphenylacetic Acid) RN - 9002-62-4 (Prolactin) RN - 9ILS801M65 (salsolinol) RN - VTD58H1Z2X (Dopamine) SB - IM MH - 3,4-Dihydroxyphenylacetic Acid/metabolism MH - Analysis of Variance MH - Animals MH - Animals, Newborn MH - Chromatography, High Pressure Liquid/methods MH - Dopamine/*metabolism MH - Electrochemistry/methods MH - Female MH - Hypothalamus, Middle/*drug effects MH - Injections, Intraventricular/methods MH - Isoquinolines/*pharmacology MH - Lactation/*physiology MH - Male MH - Pituitary Gland/*drug effects MH - Prolactin/*blood MH - Sheep MH - Time Factors EDAT- 2009/10/27 06:00 MHDA- 2010/03/10 06:00 CRDT- 2009/10/27 06:00 PHST- 2009/07/15 00:00 [received] PHST- 2009/10/12 00:00 [revised] PHST- 2009/10/14 00:00 [accepted] PHST- 2009/10/27 06:00 [entrez] PHST- 2009/10/27 06:00 [pubmed] PHST- 2010/03/10 06:00 [medline] AID - S0006-8993(09)02211-2 [pii] AID - 10.1016/j.brainres.2009.10.033 [doi] PST - ppublish SO - Brain Res. 2010 Jan 11;1307:72-7. doi: 10.1016/j.brainres.2009.10.033. Epub 2009 Oct 21.